More than 80% of DKA cases associated with SGLT2 inhibitors involved type 2 diabetes
Conversion of pro-c-MET to mature c-MET structures [3] Similar to c-MET, hepatocyte growth factor (HGF) is also synthesized as an inactive precursor (pro-HGF)
What the research shows To explore whether GLP-1 medications are associated with increased risk of gastrointestinal conditions, a recent study compared over 200,000 individuals taking GLP-1 medications with a group taking other type 2 diabetes medications (1)
Incretins at least partially mediate their effects through regulation of appetite reduction, suppression of gastric emptying, and post-prandial glucose stimulation and as such have attractive characteristics for combination with amylin and/or DACRAs [146,147]
The results showed expected improvements in: Weight reduction Cholesterol levels Hemoglobin A1C , a marker of diabetes But what was more interesting were the findings related to rheumatoid arthritis